28.11.2016 • NewsElaine BurridgeITCCASE

US to Probe Chinese Sweetener Imports

(c) John Archeri/Stockphoto
(c) John Archeri/Stockphoto

The US International Trade Commission (ITC) is to investigate imports of high-potency sweeteners by three Chinese companies after Celanese filed a complaint on Oct 26. The Dallas, Texas-headquartered chemical company alleges that the companies have infringed its patent and violated US law by importing certain sweeteners, specifically acesfulfame potassium, or Ace-K, into the country. The identified respondents are Suzhou Hope Technology, Anhui Jinhe Industrial and VitaSweet. 

Celanese’s complaint centers on alleged violations of section 337 of the 1930 US Tariff Act. The company has asked the ITC to issue a general or limited exclusion order, and cease and desist orders. The case will be assigned to an administrative law judge who will first determine – after holding an evidentiary hearing - whether or not there has been any violation of section 337. The initial determination is subject to review by the ITC. The Commission will set a target date for completing the case within 45 days from the start of the investigation.

Celanese said it intends to protect its ongoing investments in manufacturing and quality improvements and will “vigorously defend” its patented technology against unlawful importation and uses in the US.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.